Redeye: Xavi Solutions - Temporary market challenges
Redeye provides a research update on the back of Xavi Solutions’ Q1 2023 report. Net sales came in somewhat below our expectations, mainly stemming from a loss of headcount in the quarter, while the EBIT was stronger than anticipated. Overall, we revisit our forecasts, which affects our fair value range slightly.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/